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Population kinetics of the agent of human granulocytic ehrlichiosis (aoHGE) were examined
after needle and tickborne inoculation of C3H mice. Blood, skin, lung, spleen, liver, kidney,
brain, lymph node, and bone marrow samples were analyzed by using real-time polymerase
chain reaction (PCR) at various intervals after inoculation, using a p44 gene target. The highest
number of copies of the p44 gene target occurred in blood and bone marrow samples, em-
phasizing aoHGE leukocytotropism. Numbers of copies of the p44 gene target in other tissues
reflected vascular perfusion rather than replication. Needle-inoculated infected mice had ear-
lier dissemination, but kinetics of infection in both groups were parallel, with declining rates
of infection by day 20 and recovery in some mice on days 20–60 after inoculation. On the
basis of an aoHGE lysate ELISA, mice seroconverted by day 10 after inoculation. Therefore,
real-time PCR is useful for quantitative studies with the aoHGE in experimental infections,
and results showed that needle inoculation can be used to study the aoHGE infection because
of its similarity to tickborne inoculation.
Human granulocytic ehrlichiosis (HGE) was recognized as a
zoonotic disease in 1994 [1] and has been reported in regions of
the United States [2, 3] and Europe [4, 5]. The agent of HGE
(aoHGE) is transmitted from reservoir hosts to humans and/or
susceptible animals primarily by ticks of the Ixodes persulcatus
complex. HGE is manifested by fever, myalgia, leukopenia, and
thrombocytopenia and can be fatal in some cases because of
secondary complications [6, 7]. During the acute stage of infec-
tion, clusters of intracytoplasmic replicating organisms (morulae)
are found in the cytoplasm of circulating granulocytes [8, 7]. The
nucleotide sequence of the 16s RNA gene of the aoHGE has
revealed high homology with 16s RNA genes of Ehrlichia equi
and E. phagocytophila [9], which are agents associated with simi-
lar diseases in domestic animals, suggesting that they may be the
same organism with minor genetic differences [10].
The pathogenesis of HGE can be studied, under laboratory
conditions, with a number of animal models, such as horses
[10], nonhuman primates [11], rabbits [12], dogs [13], and mice
[14, 15]. Common methods of infecting laboratory animals in-
clude needle inoculation with cell culture–derived organisms or
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with blood from infected animals, as well as by allowing in-
fected nymphal Ixodes ticks to feed on experimental hosts [15,
16, 17, 14]. Efficiency of transmission by both needle and tick-
borne inoculation is high and consistent, but the kinetics of
infection in horses with the aoHGE indicate differences between
these 2 methods of inoculation [17].
Perhaps the most utilitarian animal model for investigation
of HGE pathogenesis is the inbred laboratory mouse, because
of the armamentarium of investigative tools available for work
with this species [14]. Because mice can be readily infected with
the aoHGE by tickborne inoculation and because this route
resembles natural infection, needle inoculation offers better
consistency, control, and convenience for experimental studies.
This study was undertaken to compare these 2 routes of inocu-
lation and to determine the kinetics of infection and tissue
distribution of the aoHGE during acute and chronic phases of
infection after both routes of inoculation. To accomplish this,
we used real-time polymerase chain reaction (PCR) for maximal
sensitivity and quantitative analysis.
Materials and Methods
Mice. Three- to 5-week-old C3H/HeN (C3H) and C3H/
Smn.CIcrHsd-scid (SCID) mice were purchased from Frederick
Cancer Research Center and Harlan Sprague Dawley, respectively.
Mice were maintained in a pathogen-free room in isolator cages
and were provided with a commercial laboratory diet and water
ad libitum.
aoHGE. The NCH-1 isolate of the aoHGE, a human isolate
from Nantucket, Massachusetts [14], was maintained by serial
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SCID mouse passage, and the infection status was monitored by
examining peripheral blood smears for morulae, as described else-
where [15]. Mouse-passaged aoHGE was used for infection studies.
In addition, the aoHGE was cultivated in HL-60 cell cultures for
antigen (see ELISA below), as described elsewhere [15].
Infection of ticks. I. scapularis adults collected in New Haven,
Connecticut, fed on uninfected rabbits until repletion and then were
kept in a humidified chamber for oviposition. After hatching, larvae
were tested and were sent to the University of California, Davis.
Larvae were allowed to feed to repletion on aoHGE-infected C3H
mice or uninfected mice (controls) and then were held at 21C and
190% relative humidity until they molted into nymphs. C3H mice
used for infestation were inoculated by intraperitoneal (ip) injection
with blood obtained from aoHGE-infected and uninfected SCID
mice (controls). Ten days after inoculation, each mouse was infested
with 1100 larvae. All ticks used in this study were derived from a
single cohort of larvae. The percentage of infection and the number
of organisms per tick were determined by testing 10% of the cohort
of molted nymphs, using real-time PCR.
PCR. DNA used for PCR was extracted from ticks or from
blood and tissue samples collected from mice at necropsy, using
DNeasy tissue kits (Qiagen) according to the manufacturer’s instruc-
tions. Before DNA extraction, all tissue samples were weighed, or
aliquots from 50 mL of blood were obtained. For real-time quanti-
tative PCR, 3 oligonucleotides (2 primers and a probe for the p44
target gene; GenBank accession no. AF037599) were selected by
means of Primer Express software (PE Biosystems). This target was
selected because multiple p44 genes encode 44-kDa major outer
membrane proteins of the aoHGE that elicit dominant immune re-
sponses during early and late infection. Furthermore, immunization
with these antigens partially protects mice from aoHGE challenge
[18, 19]. Primers P44-802F (5′-ACGTCGAAAAAGGCGGAAA-3′)
and P44-872R (5′-GCTACAGCTGCCGCGTTATC-3′) were syn-
thesized to amplify a 71-bp fragment of a C-terminal conserved re-
gion of the HGE p44 gene. The internal oligonucleotide probe P44-
825P (5′-TGCAGGCACTCCGGAACCCGT-3′) was labeled at the
5′ end with the reporter dye 6-carboxy-fluorescein and at the 3′ end
with the quencher dye 6-carboxy-tetramethyl-rhodamine. All reac-
tion mixes were set up in an area isolated from PCR product analysis
and sample preparation. DNA preparation, reaction assembly, and
sample analysis were done in a dedicated area, using dedicated pi-
pettors. Each PCR set-up included negative controls of no enzyme
or a template control and an unrelated DNA control. Amplification,
data acquisition, and data analysis were performed in an ABI Prism
7700 Sequence Detector (PE Applied Biosystems). Quantification of
the amount of HGE p44 gene in samples was accomplished by using
an absolute standard curve, to determine the starting number of
copies. A Sequence Detection System software (version 1.6; Perkin
Elmer) was used to analyze data, and results were exported to a
Microsoft Excel worksheet for statistical analysis.
To quantify the numbers of copies of the HGE p44 gene target
in samples, a plasmid standard was prepared. Concentration of the
plasmid with the insert was measured at a wavelength of A260 and
was converted to the number of copies by using the molecular
weight of DNA. To create a standard curve, plasmid DNA was
used as template and was diluted in a 1010-fold dilution series. Each
plasmid DNA dilution representing the plot of the log of copy
numbers versus values for the threshold cycle, which was defined
using cycles 3–9 as baseline, was included in each PCR, which then
was used to calculate an unknown amount of DNA in examined
samples. The analytical sensitivity was 1–109 copies.
ELISA. Purified aoHGE was prepared with a discontinuous
density Renografin gradient (Braccon Diagnostics), as described
elsewhere [20]. To determine IgM and IgG titers, indirect ELISA
was used. Microtiter plates (96-well; Nunc-Immuno MaxiSorp)
were coated by adding, in alternate rows, purified aoHGE or un-
infected HL-60 cell lysate at a concentration of 1 mg/mL in car-
bonate buffer (pH 9.6) and were incubated overnight at 40C. Plates
were washed and blocked with 1% bovine serum albumin. After
washing, 100 mL of serial 2-fold dilutions of serum samples from
experimentally infected or control mice (starting at 1:50) were
added to each well and were incubated overnight at 4C. The plates
were washed again and then were incubated for 2 h with 100 mL
of alkaline phosphatase–conjugated rat antibody to mouse IgG
heavy and light chains (Jackson ImmunoResearch Laboratories)
diluted 1:750. Plates were read on a dual-mode setting on an
ELISA reader after color development (test wavelength, 405 nm;
reference wavelength, 650 nm; Molecular Devices Corporation).
Optimal concentrations of each substrate and timing were estab-
lished before this experiment. Net absorbency value for each di-
lution of every serum sample was determined by subtracting HL-
60 lysate values from their respective aoHGE values. Cut-off values
were established on the basis of 3 SDs above the mean absorbance
of normal mouse serum ( ). Titers were expressed as recip-np 15
rocal serum dilutions.
Results
The experiment was designed to compare the kinetics of in-
fection in C3H mice, after needle inoculation with blood from
infected SCID mice, with the kinetics of infection after tick
feeding. If the kinetics of infection by these routes of inoculation
were sufficiently similar, the results would justify the use of
needle inoculation for a more controlled approach in experi-
mental studies.
Fifty-four ticks from the pool of 538 nymphal ticks used for
inoculation were tested individually by PCR, to determine the
percentage infection rate. Of the ticks tested, 37 (68.5%) were
found to be aoHGE PCR-positive. Among ticks that were posi-
tive, the number of copies of the p44 gene target per tick was
as low as 103 and as high as 106 ( , 5mean SD 8.34 10 
copies). Twenty-one of the 211 ticks in the uninfected51.04 10
tick pool were tested and were found to be negative.
Forty-eight C3H mice were inoculated by placing aoHGE-
infected nymphal I. scapularis ticks on the dorsal cervical mid-
line. Six infected nymphs were placed on each mouse and were
allowed to feed to repletion. Twelve control mice were sham
inoculated with uninfected ticks. Engorged nymphs were col-
lected and individually tested by using PCR. Among 203 ticks
from the infected group that were recovered after feeding to
repletion, the p44 gene target was detected in 121 ticks (59.6%)
from the infected tick pool, indicating that each mouse was
exposed to 2–6 infected ticks. In contrast, none of the 51 un-
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Table 1. Agent of human granulocytic ehrlichiosis polymerase chain reaction (PCR) results from tissues of needle- and
tick-inoculated infected mice, at various time intervals after inoculation.
Necropsy day,a
route of
inoculation Skin Blood
Prescapular
lymph
nodes
Mesenteric
lymph
nodes Liver Spleen Kidneys Lungs Brain
Bone
marrow Total
3
Needle 3/4 4/4 4/4 4/4 4/4 4/4 4/4 4/4 4/4 4/4 4/4 (100)
Tick 2/8 3/8 5/8 1/8 1/8 3/8 2/8 4/8 3/8 2/8 5/8 (62.5)
5
Needle 3/4 4/4 4/4 4/4 4/4 4/4 4/4 4/4 4/4 4/4 4/4 (100)
Tick 6/8 6/8 6/8 5/8 4/8 6/8 4/8 6/8 4/8 5/8 6/8 (75)
10
Needle 4/4 4/4 3/4 4/4 4/4 4/4 4/4 4/4 4/4 4/4 4/4 (100)
Tick 2/8 2/8 2/8 2/8 2/8 2/8 2/8 2/8 0/8 2/8 2/8 (25)
20
Needle 1/4 4/4 1/4 0/4 2/4 3/4 0/4 2/4 0/4 1/4 4/4 (100)
Tick 0/8 5/8 4/8 5/8 3/8 3/8 2/8 2/8 3/8 4/8 5/8 (62.5)
30
Needle 2/4 3/4 1/4 1/4 3/4 3/4 1/4 1/4 1/4 2/4 3/4 (75)
Tick 0/8 3/8 5/8 2/8 1/8 3/8 2/8 2/8 2/8 2/8 5/8 (62.5)
60
Needle 0/4 2/4 0/4 0/4 1/4 0/4 0/4 0/4 0/4 1/4 2/4 (50)
Tick 0/8 1/8 0/8 1/8 2/8 0/8 0/8 1/8 0/8 2/8 2/8 (25)
NOTE. Data are no. of PCR-positive mice/no. of mice tested (%).
a Days after needle inoculation (days 5, 7, 12, 22, 32, and 62 after tick attachment, respectively).
Figure 1. Mean nos. of copies of the agent of human granulocytic
ehrlichiosis p44 DNA (SD) in blood from mice infected by needle
or tickborne inoculation, at different time points after infection.
infected engorged ticks collected from control mice was found
to be positive.
For needle inoculation, mice were injected ip with infectious
material, because previous studies have found that intradermal/
subcutaneous inoculation requires a higher infectious dose [15].
It has been shown that ticks transmit the aoHGE 36–48 h after
tick attachment [21, 20]. Therefore, to synchronize both ex-
perimental groups, needle inoculation of mice was done at 48
h after tick attachment in the other group. In addition, 24 C3H
mice were inoculated ip with 0.1 mL of EDTA-anticoagulated
blood pool from infected SCID mice (the percentage of granu-
locytes with morulae was adjusted to 10% by diluting blood
with PBS). Six control mice were inoculated with serum from
uninfected SCID mice. In an effort to approximate the aoHGE
dose used in this experiment, similarly derived blood from in-
fected SCID mice (same interval of infection, 10% morulae, 1
mL) was tested and found to contain copies of the p4466 10
gene target.
On days 3, 5, 10, 20, 30, and 60 after inoculation (days 5,
7, 12, 22, 32, and 62 after tick attachment), 4 mice from the
needle inoculation group and 8 mice from the tickborne in-
oculation group, as well as 1 mouse from the needle inoculation
control group and 2 mice from the tickborne inoculation control
group, underwent necropsy at each interval. Skin, lung, spleen,
liver, kidney, brain, prescapular lymph nodes, mesenteric lymph
nodes, bone marrow (femoral and tibial), and blood samples
were collected for DNA extraction and PCR.
Infected mice were clinically normal, and the only discernable
gross pathology among infected mice was splenomegaly. The
mean spleen weight of control mice was 90 mg (SD, 17.6
mg), whereas the mean spleen weights on days 10, 20, and 30
of needle-inoculated infected mice and of tick-inoculated in-
fected mice were 205.9 mg (SD, 32.7 mg) and 187.1 mg (SD,
108 mg), respectively.
Infection was confirmed by PCR for all needle-inoculated in-
fected mice on days 3–20, but 75% of tick-inoculated infected
mice were PCR positive at any interval (table 1). In contrast, all
10 tissue sites from all 18 control mice that were infected by
needle and tickborne inoculation were PCR negative. Among
infected mice, the p44 gene target could be amplified from all
tissues tested. Analysis of tissue distribution of the aoHGE re-
vealed that the agent was distributed unevenly in tick-inoculated
infected mice on days 3 and 5, but needle-inoculated infected
mice had nearly universal infection of all tissues at these intervals.
Comparison of the tissue distribution of aoHGE between the
groups revealed no differences in distribution in mice examined
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Table 2. Comparison of nos. of copies of the agent of human granulocytic ehrlichiosis (aoHGE) p44 DNA extracted from different tissues of
mice infected by needle and tickborne inoculation, at various time intervals after inoculation.
Days
after needle
inoculation,a
route of
inoculation Skinb Bloodc
Prescapular
lymph
nodes
Mesenteric
lymph
nodes Liver Spleen Kidney Lung Brain
Bone
marrowd
3
Needle 128117 12170288898 285317 18489 661592 37932867 6241 295399 169 822936
Tick 1.251.5 6361010 177323 52104 236323 280560 12.524.4 188353 8.216 31006200
5
Needle 5.46 14552564705 4118 117114 7872 748463 2010 3821 2012 199237
Tick 5.35 1033967 318392 291158 11171603 16201596 166250 440547 10.415.6 44233652
10
Needle 270266 574800590303 7911180 201128 19242105 780510960 325412 871513930 4241 141187
Tick 478484 13731240 60732 146 50151097 12256 74396 655339 0 3776015358
20
Needle 4.38.6 11391132 3.567.13 0 1.32 5.76.6 0 6.512 0 4.99.8
Tick 0 11654 2910 6758 13367 276192 101 9027 41 313099
30
Needle 4.76.7 48277685 3.86.6 2.54.3 55 6998 23.4 1.52.5 21 3031
Tick 0 151220 12161983 190168 128221 289487 2627 76129 4.75 38563781
60
Needle 0 27803592 0 0 1.82.5 0 0 0 0 5476
Tick 0 4.76.6 0 45.6 6.52.6 0 0 3.55 0 1251443
NOTE. Data are nos. of copies of aoHGE p44 DNA, expressed as of positive samples.meanSD
a Days 5, 7, 12, 22, 32, and 62 after tick attachment, respectively.
b No. of copies of aoHGE p44 DNA was expressed per microgram of tissue after adjusting the real-time polymerase chain reaction to the volume of the aliquot
and the tissue weight.
c No. of copies in blood samples, as determined in 50 mL of purified blood.
d No. of copies of aoHGE p44 DNA was expressed per microgram of bone marrow DNA.
Figure 2. Mean nos. of copies of the agent of human granulocytic
ehrlichiosis p44 DNA (SD) in bone marrow from mice infected by
needle or tickborne inoculation, at different time points after
inoculation.
on days 20, 30, and 60 after needle inoculation (days 22, 32, and
62 after tick attachment; table 2).
Quantitative analysis of the aoHGE p44 gene target in vari-
ous tissues at intervals after infection revealed no significant
differences ( , unpaired Student’s t test) in skin, prescapu-P 1 .05
lar lymph nodes, mesenteric lymph nodes, spleen, kidneys,
lungs, liver, and brain, and numbers of copies of the p44 gene
target in these organs tended to be low. In contrast, significantly
higher numbers of copies of the p44 gene were found in blood
and bone marrow samples, but blood was clearly the predomi-
nant target organ for the aoHGE (figures 1 and 2). Mice in-
fected by needle inoculation had significantly higher numbers
of copies of the p44 gene target in blood, compared with tick-
inoculated infected mice, at days 3 and 5 ( ).P ! .05
The kinetics of blood and bone marrow infection in mice
infected with the aoHGE by needle inoculation versus those
infected by tickborne inoculation were parallel, but needle-in-
oculated infected mice maintained consistently higher numbers
of copies of the p44 gene target in blood, and tick-inoculated
infected mice maintained consistently higher numbers of copies
of the organism in bone marrow (figures 1 and 2; , daysP ! .05
10 and 20). After day 10, numbers copies in infected mice de-
clined in blood and bone marrow, as well as in all other tissues,
in both groups (table 2; figures 1 and 2).
Seroconversion to aoHGE antigen, as detected by ELISA,
occurred by day 10 in both groups. The mean ELISA titers in
both groups of infected mice at any time point after inoculation
were similar (figure 3). All mice infected with the aoHGE by
needle inoculation seroconverted to the aoHGE antigen on days
10 and 20, and all aoHGE-inoculated infected mice that appar-
ently had cleared infection, on the basis of PCR, by days 30 and
60 were seropositive. Thus, seroconversion accurately reflected
infection. None of the PCR-negative tick-inoculated infected
mice seroconverted to the aoHGE antigen.
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Figure 3. IgM/IgG ELISA antibody titers to the agent of human
granulocytic ehrlichiosis (aoHGE) in polymerase chain reaction–
positive mice, at various intervals after infection by needle and tick-
borne inoculation.
Discussion
In a previous study [15], we were unable to detect the aoHGE
in mice beyond 30 days after tickborne inoculation, using blood
smears, HL-60 culture, and conventional PCR. Nevertheless,
infection with the aoHGE was verified by xenodiagnosis at day
55 after inoculation. These observations emphasized the need
to develop more-sensitive assays for the detection of the aoHGE
in experimental studies. By using real-time PCR analysis, we
were able to detect the aoHGE in both needle- and tick-in-
oculated infected mice at any time point from day 3 to day 60
after infection.
Real-time PCR offers not only sensitivity but also quantitative
analysis of the kinetics of infection. By comparing needle inocula-
tion with tickborne inoculation infection in various organs and
at intervals 60 days after inoculation, we have shown that
peripheral blood is the predominant target organ for the aoHGE.
Involvement of a variety of tissues, such as skin, lymph nodes,
kidneys, lungs, and brain, which were PCR positive but which
had low numbers of target copies of the p44 gene, suggests that
the involvement of these organs is passive and probably a re-
flection of the blood within the vasculature of these sites. In-
volvement of the spleen and liver probably reflects, to a somewhat
greater extent, the reticuloendothelial function of these organs,
as well as the propensity of both organs to support extrame-
dullary myelopoeisis in the adult mouse. The high rate of infec-
tion and relatively high numbers of copies of the aoHGE p44
gene target in bone marrow is expected for an agent that replicates
in hematopoeitic tissues. Thus, these results reinforce the notion
that the aoHGE replicates in granulocytic and, occasionally,
monocytic lineages [22, 23] without other host tissue targets.
Experimental studies with the aoHGE are fraught with sig-
nificant difficulties in defining the infectious dose of the organ-
ism. This also was true in our study, since there was no way
to equilibrate infectious dose between tickborne and needle in-
oculation. The biologic nature of the agent derived from these
routes of inoculation is also likely to differ, since tickborne
organisms are delivered to the host in an extracellular mode
[14], whereas needle inoculation uses intracellular organisms.
Furthermore, because the aoHGE replicates intracellularly, or-
ganisms cannot be quantified into infectious units in either ticks
or blood samples, and numbers of copies of the gene target
copy numbers may not necessarily reflect infectious units of
organisms. Furthermore, our studies show that the numbers of
copies of aoHGE organisms in ticks are highly variable and
that not all mice become infected, even when 6 nymphal ticks
were allowed to feed to repletion. We have shown elsewhere
[20] that relatively large numbers (104–105) of the aoHGE are
needed to infect mice. Others have suggested that large numbers
of infected ticks are needed for successful transmission [17, 24].
On the other hand, one study demonstrated a very high rate
of infection of mice after infestation with 5–8 infected nymphs
[14]. These differences no doubt reflect variables in isolate, num-
bers within ticks, and numbers of ticks used for inoculation
but underscore the problems that are consistent with tickborne
infection in experimental studies.
Needle inoculation with the aoHGE is also less than ideal,
because the organism is more efficiently transmitted by ip in-
oculation, compared with the putatively more natural route of
cutaneous inoculation [15], and it is difficult to standardize
infectious dose between studies. Nevertheless, needle inocula-
tion offers standardization of dose within a given experiment
and a more consistent rate of infection, as the current study
demonstrated. This study was undertaken to determine whether
needle and tickborne inoculation were of sufficient similarity
that the more controlled, needle-inoculation method could be
used with some degree of assurance that it mimicked natural
infection. Results suggest that the kinetics of infection, target
organs, and clearance patterns are basically similar, regardless
of the inoculation method. The earlier and higher titers of
aoHGE organisms in various tissues and the higher antibody
titers to the aoHGE during active infection in needle-inoculated
infected mice suggest that the mice received a higher infectious
dose but that the basic kinetics of and response to infection in
the 2 routes of inoculation were similar.
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